European Foundation for the Study of Diabetes (EFSD)
and the
Chinese Diabetes Society (CDS)
and
Lilly
Programme for Collaborative Diabetes Research
between China and Europe
Request for Applications (RFA)
EFSD and CDS and Lilly
announce
Funding of Research Grants
in 2008
Extended Deadline: 24
October 2008
Background
The European Association for the Study of Diabetes (EASD) was founded in Montecatini, Italy, in 1965. In 1999, the Association
created the
European Foundation for the Study of Diabetes (EFSD). The aims of EFSD are to encourage and support research
in the field of diabetes,
to rapidly diffuse acquired knowledge and to facilitate its application.
Founded in 1991, the Chinese Diabetes Society conducts public education programmes, epidemiological surveys and research in China.
The mission of CDS
is to prevent and treat diabetes and provide information to
help educate people living with diabetes, their families, health care professionals, and the public about this disease.
Lilly is a world leader
in insulin production and also manufactures and
markets a variety of other pharmaceutical products. The headquarters of Lilly is in Indianapolis, Indiana, USA.
Programme
EFSD and CDS and Lilly have established a new partnership to target collaborative research endeavours between
European and Chinese research centres and/or individual investigators in the area of diabetes and its complications.
Funding Commitment and Instruments
A total funding of Euro 1.5 million has been committed from 2008 – 2010. Two
basic science research grants in the sum of up to Euro 100,000 and one clinical
outcomes research grant in the sum of up to Euro 200,000 will be made available
annually, for research to be carried out in China in collaboration with a
European research institution.
To achieve the goals and objectives of this Programme, EFSD and CDS and
Lilly invite applications by issuing this "Request for Applications" (RFA), which indicates joint funding as
well as areas of research emphasis.
Funding
In 2008 two basic research grants of up to Euro 100,000 and one clinical research grant of up to Euro 200,000 are available.
Mechanism of Support and Review
The duration of each grant award may be one year or longer, depending upon the needs of the project and as justified in the a
pplication, so long as the total budget does not exceed the sum of Euro 100,000 for basic research projects and Euro 200,000
for clinical research projects. The Programme Board, on advisement from the Review Committee, may on occasion and at its discretion
recommend an award in a lesser amount considered more appropriate for the proposed studies.
Applications for an EFSD/CDS/Lilly grant are invited from single non-profit institutions or groups of such institutions
from China in collaboration with research institutions in Europe and associated countries, The principal investigator and any
co-investigators must be employed full-time at a non-profit institution and the study must be performed at the place of work.
The main part of the research project should be
carried out in the Chinese institution, with the collaborating European institution acting in an advisory capacity.
Applications will be subject to scientific review by a specialised ad hoc committee. Funding will require approval by a
joint EFSD and CDS and Lilly Board convened for this purpose. It is anticipated that
applications for the grant year 2008 will be received, reviewed and approved for funding by December 2008
Research Grant Applications
Applications for research grants may be subjected to pre-review (or triage) procedures. In this event,
any application rejected at pre-review will not be subject to a complete scientific review.
The deadline for receipt of research grant applications for funding this year is
25 September 2008.
All budgets are to be prepared in Euro. For countries in which the Euro
is not yet the common currency, the exchange rate (between the Euro and the local currency in the country where the work
is to be performed) used for calculating the Euro budget must be mentioned under "Budget Justification". EFSD and CDS and
Lilly reserve the right to increase
or decrease approved funding in Euro amounts to compensate for any significant change in the exchange rate.
Application forms may be requested from:
Foundation@easd.org
All applications must be prepared
on the official forms and completed in strict accordance with the detailed instructions to be found on these forms.
In particular, applicants are reminded that any pages in addition to the maximum of 10 allowed for the scientific section of
the application will be deleted prior to review. Similarly, no applications using a font or line-spacing smaller than that defined
in the instructions will be considered for review.
Additional material (in the form of an appendix, attachment, reprints, etc.) will not be accepted.
Applications should be
submitted by post no later than
24 October 2008 (date of receipt) to:
Dr Viktor Jörgens
Executive Director
European Foundation for the Study of Diabetes
Rheindorfer Weg 3
40591 Düsseldorf
Germany
Review Considerations
Completed applications will be evaluated in accordance with the criteria stated below for scientific/technical merit by an appropriate scientific committee convened by
EFSD and CDS and Lilly.
Review criteria are as follows:
- Significance: Does the study address an important problem? If the aims of the application are achieved, how
will scientific knowledge be advanced? What will be the effect of the proposed studies on the concepts or methods that
drive this field?
- Approach: Are the conceptual framework, design, methods and analyses adequately developed, well integrated,
and appropriate to the aims of the project? Does the applicant acknowledge potential problem areas and consider
alternative tactics?
- Innovation: Does the project employ novel concepts, approaches or methods? Are the aims original and
innovative? Does the project challenge existing paradigms or develop new methodologies or technologies?
- Investigator: Is the investigator appropriately trained and well suited to carry out this work? Is the
work proposed appropriate to the experience level of the principal investigator and other researchers,
if any?
- Environment: Does the scientific environment in which the work will be done contribute to the probability
of success? Do the proposed experiments take advantage of unique features of the scientific environment or employ
useful collaborative arrangements? Is there evidence of institutional support?
- Budget: Is the requested budget appropriate for the proposed study?
Reporting Requirements
All investigators funded by this Programme are required to submit a scientific report
at the end of the funding period. Investigators must provide EFSD with copies of papers accepted for publication,
and must acknowledge the support of the Programme in all written material by use of the phrase:
"Supported by an EFSD/CDS/Lilly research grant".
Schedule
| Announcement: |
May 2008 |
| Application Deadline: |
24
October 2008 |
| Anticipated Award: |
December 2008 |
Enquiries should be directed to:
Dr. Viktor Jörgens
Executive Director
European Foundation for the Study of Diabetes
Rheindorfer Weg 3
40591 Düsseldorf
Germany
Tel: +49-211-758469-0
Fax: +49-211-75846929
E-mail: Foundation@easd.org
|